Entering text into the input field will update the search result below

Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT). June. Short. +52.64% On Invested Capital.

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Summary

  • Investors are very fond of the result.
  • I propose to calculate the potential profit for June.
  • The forecast were printed on May 31, 2020.

June 10

Short

Volume position 1000 shares.

Position opening: $ 81.95.

$ 81.95 x 1000 shares = $ 81,950. This is the invested capital.

Stop Loss: $ 83.20

June 11

On my strategy at the price of $ 73.95, 50% of the position was closed.

$ 81.95 x 1000 shares = $ 81,950

$ 73.95 x 1000 shares = $ 73,950

$ 81,950 - $ 73,950 = $ 8,000. This is 9.76% on invested capital.

We continue to hold the position.

$ 81.95 x 500 shares = $ 40,975

June 23

Closing position June 10

$ 81.95 x 500 shares = $ 40,975

$ 81.65 x 500 shares = $ 40,825

$ 40,975 - $ 40,825 = $ 150. This is 0.36% on invested capital.

June 25

Short

Volume position 1000 shares.

Position opening: $ 79.95.

$ 79.95 x 1000 shares = $ 79,950. This is the invested capital.

Stop Loss: $ 82.20

June 30

Closing position June 25

$ 79.95 x 1000 shares = $ 79,950

$ 45.95 x 1000 shares = $ 45,950

$ 79,950 - $ 45,950 = $ 34,000. This is 42.52% on invested capital.

Profit for June.

$ 8,000 + $ 150 + $ 34,000 = $ 42,150

9.76% + 0.36% + 42.52% = 52.64%

By the way. The position volume could be increased 3 times. This is for this ticker.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.